155 related articles for article (PubMed ID: 20126270)
1. A CATT negative result after treatment for human African trypanosomiasis is no indication for cure.
Lejon V; Ngoyi DM; Boelaert M; Büscher P
PLoS Negl Trop Dis; 2010 Jan; 4(1):e590. PubMed ID: 20126270
[TBL] [Abstract][Full Text] [Related]
2. Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African Trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in southern Sudan.
Chappuis F; Stivanello E; Adams K; Kidane S; Pittet A; Bovier PA
Am J Trop Med Hyg; 2004 Sep; 71(3):313-7. PubMed ID: 15381812
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa.
Truc P; Lejon V; Magnus E; Jamonneau V; Nangouma A; Verloo D; Penchenier L; Büscher P
Bull World Health Organ; 2002; 80(11):882-6. PubMed ID: 12481210
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study.
Büscher P; Mertens P; Leclipteux T; Gilleman Q; Jacquet D; Mumba-Ngoyi D; Pyana PP; Boelaert M; Lejon V
Lancet Glob Health; 2014 Jun; 2(6):e359-63. PubMed ID: 25103304
[TBL] [Abstract][Full Text] [Related]
5. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis.
Lejon V; Roger I; Mumba Ngoyi D; Menten J; Robays J; N'siesi FX; Bisser S; Boelaert M; Büscher P
Clin Infect Dis; 2008 Jul; 47(1):15-22. PubMed ID: 18494605
[TBL] [Abstract][Full Text] [Related]
6. The phenomenon of treatment failures in Human African Trypanosomiasis.
Brun R; Schumacher R; Schmid C; Kunz C; Burri C
Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
[TBL] [Abstract][Full Text] [Related]
7. Parasitological detection of Trypanosoma brucei gambiense in serologically negative sleeping-sickness suspects from north-western Uganda.
Enyaru JC; Matovu E; Akol M; Sebikali C; Kyambadde J; Schmidt C; Brun R; Kaminsky R; Ogwal LM; Kansiime F
Ann Trop Med Parasitol; 1998 Dec; 92(8):845-50. PubMed ID: 10396344
[TBL] [Abstract][Full Text] [Related]
8. Field evaluation of the CATT/Trypanosoma brucei gambiense on blood-impregnated filter papers for diagnosis of human African trypanosomiasis in southern Sudan.
Chappuis F; Pittet A; Bovier PA; Adams K; Godineau V; Hwang SY; Magnus E; Büscher P
Trop Med Int Health; 2002 Nov; 7(11):942-8. PubMed ID: 12390600
[TBL] [Abstract][Full Text] [Related]
9. Control of human African trypanosomiasis in the Quiçama focus, Angola.
Ruiz JA; Simarro PP; Josenando T
Bull World Health Organ; 2002; 80(9):738-45. PubMed ID: 12378293
[TBL] [Abstract][Full Text] [Related]
10. The elimination of Trypanosoma brucei gambiense sleeping sickness in the focus of Luba, Bioko Island, Equatorial Guinea.
Simarro PP; Franco JR; Ndongo P; Nguema E; Louis FJ; Jannin J
Trop Med Int Health; 2006 May; 11(5):636-46. PubMed ID: 16640616
[TBL] [Abstract][Full Text] [Related]
11. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
Nok AJ
Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo.
Balasegaram M; Harris S; Checchi F; Hamel C; Karunakara U
Bull World Health Organ; 2006 Oct; 84(10):777-82. PubMed ID: 17128357
[TBL] [Abstract][Full Text] [Related]
13. Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo.
Pyana Pati P; Van Reet N; Mumba Ngoyi D; Ngay Lukusa I; Karhemere Bin Shamamba S; Büscher P
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3212. PubMed ID: 25275572
[TBL] [Abstract][Full Text] [Related]
14. Current chemotherapy of human African trypanosomiasis.
Docampo R; Moreno SN
Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the reactivity of the card agglutination test for trypanosomiasis (CATT) reagent in the Fontem sleeping sickness focus, Cameroon.
Asonganyi T; Bedifeh BA; Ade SS; Ngu JL
Afr J Med Med Sci; 1994 Mar; 23(1):39-46. PubMed ID: 7839945
[TBL] [Abstract][Full Text] [Related]
16. [A strategy to control Trypanosomiasis due to Trypanosoma brucei gambiense in an endemic region of Zaire. Association of a serological test and early treatment of suspected cases. Preliminary results].
De Groof D; Bruneel H; Mungoma K; Ruppol JF
Bull Soc Pathol Exot; 1993; 86(4):260-3. PubMed ID: 8292915
[TBL] [Abstract][Full Text] [Related]
17. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
[TBL] [Abstract][Full Text] [Related]
18. The treatment of human African trypanosomiasis.
Pépin J; Milord F
Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565
[No Abstract] [Full Text] [Related]
19. Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa.
Jamonneau V; Bucheton B; Kaboré J; Ilboudo H; Camara O; Courtin F; Solano P; Kaba D; Kambire R; Lingue K; Camara M; Baelmans R; Lejon V; Büscher P
PLoS Negl Trop Dis; 2010 Dec; 4(12):e917. PubMed ID: 21200417
[TBL] [Abstract][Full Text] [Related]
20. [Human African trypanosomiasis in Ivory Coast: biological characteristics after treatment. 812 cases treated in the Daloa focus (Ivory Coast)].
Miezan TW; Dje NN; Doua F; Boa F
Bull Soc Pathol Exot; 2002 Dec; 95(5):362-5. PubMed ID: 12696377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
